Tamoxifen (20mg) . .. . . . .

Tamoxifen IP (20mg)
TAMOXIFLOW is a medication that belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). TAMOXIFLOW is commonly used in the treatment of breast cancer, particularly in hormone receptor-positive breast cancers. Hormone receptor-positive breast cancers have receptors for estrogen and/or progesterone on the surface of their cells, and these hormones can stimulate the growth of cancer cells.
TAMOXIFLOW works by blocking the effects of estrogen in the breast tissue. TAMOXIFLOW does this by binding to the estrogen receptors on the surface of cancer cells, preventing estrogen from attaching to these receptors. This helps to inhibit the growth and division of hormone receptor-positive breast cancer cells.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
info@sterispharma.com
order now:
https://www.sterisonline.com/product/tamoxiflow-20-133999